Called Back After a Mammogram? Here’s What It Actually Means

The voicemail says the imaging center needs you to come back in for additional views. Or the portal message says your results were “incomplete” and additional imaging is needed. Either way, your stomach drops.

Before anything else, know this: a callback is not a diagnosis. It is not even close to one. It’s the imaging team saying “we saw something we couldn’t fully characterize, and we want a better look.” For most women, that better look ends with reassuring news.

Let’s walk through what’s actually happening, so the days between the call and the appointment feel less like freefall.

Why do callbacks happen?

A screening mammogram is a fast, standardized set of images taken when you have no symptoms. Radiologists read thousands of them, and their job at that stage is simply to sort: clearly fine, or worth another look.

The most common reasons for being recalled after a mammogram include:

• Overlapping or dense tissue. Dense fibroglandular tissue shows up white on a mammogram, and so do potential masses. When tissue overlaps in a certain way, it can mimic something suspicious, or hide the area the radiologist wants to see clearly.

• A possible mass or asymmetry. An area looks different from the surrounding tissue, or different from the same spot on your other breast.

• Calcifications. Tiny mineral deposits that are usually benign but occasionally warrant a closer look at their pattern.

• No prior images to compare. First mammograms get called back more often, simply because the radiologist has no baseline for what “normal” looks like in your breasts.

• Technical issues. Sometimes an image is blurred or a portion of tissue wasn’t fully captured.

Notice how many of those reasons are about image clarity, not about a finding. That’s especially true if you have dense breast tissue. On a mammogram, dense tissue and cancer both appear white, which is why mammograms miss up to 40% of cancers in women with dense breast tissue (FDA Federal Register, March 2023) and why dense tissue also triggers more “let’s take another look” callbacks.

Screening vs. diagnostic mammogram: what’s the difference?

This is the part that confuses almost everyone, so here it is plainly.

A screening mammogram is routine. You have no symptoms, the images follow a standard protocol, and a radiologist reads them after you’ve gone home.

A diagnostic mammogram is a focused exam. It’s ordered when something needs a closer look: a callback, a lump, pain, or discharge. The technologist takes additional angled or magnified views of the specific area in question, and a physician typically reviews the images while you’re still there, so you often leave with answers the same day.

Being sent for a diagnostic mammogram after a screening callback doesn’t mean your situation is more serious. It means the exam is more thorough. That’s the whole point.

What are the odds it’s actually cancer?

The honest numbers are more reassuring than your 2 a.m. imagination.

Most callbacks resolve with normal or benign findings after the additional imaging alone. Even among women who go on to have a biopsy, between 75 and 80% of breast biopsies come back benign (MD Anderson Cancer Center). A callback is the system being careful, not the system telling you something is wrong.

And in the cases where a callback does lead to finding a cancer, it’s usually finding it early, which is exactly what screening is for. When breast cancer is caught at the localized stage, the five-year survival rate is over 99% (ACS Cancer Facts & Figures 2026).

Will I need an ultrasound after my mammogram?

Very possibly, and that’s normal. Ultrasound is frequently the next step after a callback because it answers a question mammography can’t: is this area solid, or is it a fluid-filled cyst?

Ultrasound uses sound waves rather than ionizing radiation, so there’s no added radiation exposure, and it’s particularly useful in dense tissue, where it can see what white-on-white mammogram images can’t separate. If your callback letter mentions “targeted ultrasound” or “ultrasound of the breast,” it simply means the team wants that second kind of picture. (Curious how the two tools divide the work? Here’s breast ultrasound vs. mammogram, explained.)

How soon will I know?

Ask the imaging center directly, but as a general pattern: diagnostic visits are often read on the spot or within a day or two, faster than the screening result that started all this. If a biopsy is recommended, pathology typically takes several more days. The waiting is genuinely the hardest part, so it’s fair to ask, at every step, “when will I hear, and from whom?”

If your callback ends with “you have dense breasts”

Here’s the pattern so many women describe: the callback resolves, the letter says everything is normal or benign, and buried in the same report is a line noting heterogeneously dense or extremely dense breast tissue. Since September 10, 2024, the FDA requires that every woman be told her breast density after a mammogram.

That line matters. Dense tissue is what made your mammogram harder to read in the first place, and it’s a known risk factor: women with dense breast tissue are four to six times more likely to develop breast cancer than women with non-dense breasts (Boyd et al., NEJM 2007).

For exactly this situation, supplemental screening exists. Automated breast ultrasound (ABUS) is FDA-approved as a supplemental screening tool for women with dense breasts, and when added to mammography, it detects 35.7% more breast cancers than mammography alone (FDA PMA P110006). It doesn’t replace your mammogram. It fills in what your mammogram can’t see.

Coming soon to New York City

BeSound is a breast imaging platform that provides access to FDA-approved automated breast ultrasound: radiation-free, compression-free, about 20 minutes, with images interpreted by licensed physicians and results in 24 to 48 weekday hours.

A BeSound New York City location is opening soon. If you’ve been through a callback, learned you have dense breasts, and want a screening plan that actually accounts for your tissue, joining the waitlist puts you first in line when booking opens.

You did the right thing by showing up for your screening. A callback is just the next step in the same act of taking care of yourself.

Be first when we open in NYC

FDA-approved automated breast ultrasound is coming to New York. Radiation-free, compression-free, about 20 minutes, with results in 24 to 48 weekday hours. Join the waitlist and be the first to know when booking opens.

Join the NYC Waitlist

Not medical advice. Consult a medical professional with any medical questions. BeSound provides supplemental breast ultrasound imaging and does not replace mammography or medical care. Imaging is interpreted by licensed physicians. For marketing purposes only. The American Cancer Society recommends that women at average risk begin regular mammograms at age 40. BeSound is a technology platform that connects individuals with independent partner medical groups that provide breast imaging services; BeSound is not a healthcare provider.